These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10847833)

  • 21. HIV protease inhibitors.
    Winslow DL; Otto MJ
    AIDS; 1995; 9 Suppl A():S183-92. PubMed ID: 8819585
    [No Abstract]   [Full Text] [Related]  

  • 22. The daunting challenge of keeping HIV suppressed.
    Cohen J
    Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
    [No Abstract]   [Full Text] [Related]  

  • 23. After a person has built resistance to a drug and then goes on other drugs for a while, is it possible that the virus loses its resistance to the first drug after not being in their system for awhile, or will the virus be resistant to that drug for the rest of his/her life?
    Gallant JE
    Hopkins HIV Rep; 2001 Nov; 13(6):11. PubMed ID: 11727412
    [No Abstract]   [Full Text] [Related]  

  • 24. [New trends in HIV].
    Volkert R
    Dtsch Med Wochenschr; 1998 Sep; 123(38):A7. PubMed ID: 9787287
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antiretroviral resistance testing. A necessary element in the follow-up of the HIV-infected patient].
    Alcamí J; Rubio R
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):1-2. PubMed ID: 11428052
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 27. HIV/AIDS. Experts question danger of 'AIDS superbug'.
    Cohen J
    Science; 2005 Feb; 307(5713):1185. PubMed ID: 15731415
    [No Abstract]   [Full Text] [Related]  

  • 28. Are resistance puzzlers caught in a data quagmire? XIV International HIV Drug Resistance Workshop. June 7-11, 2005, Quebec, Canada.
    Mascolini M
    IAPAC Mon; 2005 Sep; 11(9):256-64, 267-75. PubMed ID: 16363042
    [No Abstract]   [Full Text] [Related]  

  • 29. Report from the XVII International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2008 Aug; 20(8):61-2. PubMed ID: 18814368
    [No Abstract]   [Full Text] [Related]  

  • 30. Predicting the unpredictable: transmission of drug-resistant HIV.
    Blower SM; Aschenbach AN; Gershengorn HB; Kahn JO
    Nat Med; 2001 Sep; 7(9):1016-20. PubMed ID: 11533704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 32. ICAAC. New resistance findings presented at annual conference.
    Rodriguez E
    Posit Living; 2002; 11(1):16. PubMed ID: 11942289
    [No Abstract]   [Full Text] [Related]  

  • 33. HIV in Europe--a growing threat.
    Wahren B
    J Clin Virol; 2001 May; 21(2):171-3. PubMed ID: 11417524
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV drug resistance in Africa: an emerging problem that deserves urgent attention.
    Moreno M; Caballero E; Mateus RM; Samba F; Gil E; Falcó V
    AIDS; 2017 Jul; 31(11):1637-1639. PubMed ID: 28481772
    [No Abstract]   [Full Text] [Related]  

  • 35. Concentration-targeted therapy and the future of HIV management.
    Flexner CW; Piscitelli SC
    AIDS; 2002 Mar; 16 Suppl 1():S1-3. PubMed ID: 12035819
    [No Abstract]   [Full Text] [Related]  

  • 36. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 37. Virological markers of progression: a UK experience.
    Loveday C
    J Biol Regul Homeost Agents; 1995; 9(3):100-4. PubMed ID: 8782016
    [No Abstract]   [Full Text] [Related]  

  • 38. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 39. Report from the XV International HIV Drug Resistance Workshop.
    Kuritzkes DR
    AIDS Clin Care; 2006 Sep; 18(9):83-4. PubMed ID: 16995272
    [No Abstract]   [Full Text] [Related]  

  • 40. [Human immunodeficiency virus and antiretroviral therapy resistance].
    Quirós E; Torti C; Carosi G
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):234-7. PubMed ID: 10974768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.